Breast Lump Histopathology
- Sample Type
- Biopsy Tissue
- Fasting
- No
- Unit
- Qualitative
Function
Histopathology is the microscopic examination of tissue to study the manifestations of disease. When a breast lump is detected via physical exam or imaging (Mammogram/Ultrasound), a small piece of the tissue is removed via biopsy. A pathologist then examines the cellular structure to determine if the lump is benign (non-cancerous) or malignant (cancerous).
Why it is Ordered
This is the definitive 'gold standard' test for breast cancer diagnosis. While imaging can suggest a lump looks suspicious, only histopathology can confirm the presence of cancer cells. It also identifies the type of cancer (e.g., Infiltrating Ductal Carcinoma) and the grade (how aggressive the cells look), which dictates the entire treatment plan.
Associated Conditions
- Fibroadenoma: A common benign breast tumor.
- Fibrocystic Changes: Non-cancerous lumps related to hormonal cycles.
- Invasive Ductal Carcinoma (IDC): The most common form of breast cancer.
- Ductal Carcinoma In Situ (DCIS): Non-invasive cancer cells in the milk ducts.
Why Context Matters
Histopathology is subjective and relies on the expertise of the pathologist. 'Gray areas' exist where cells look atypical but not clearly malignant. A second opinion from a dedicated breast sub-specialist pathologist is highly recommended to confirm the diagnosis, especially before undergoing major surgery or chemotherapy. Sampling error—where the needle misses the malignant part of the lump—is also a factor.
Lab ranges are statistical averages, not biological laws. "Normal" for a 20-year-old male isn't normal for a 60-year-old female.
Clinical References
Source-of-truth databases and clinical guidelines for Breast Lump Histopathology:
Official Sources
- Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology - PubMedpubmed.ncbi.nlm.nih.gov
- NCCN Guidelines® Insights: Breast Cancer, Version 5.2025 - PubMedpubmed.ncbi.nlm.nih.gov
- NCCN Guidelines® Insights: Breast Cancer, Version 4.2023 - PubMedpubmed.ncbi.nlm.nih.gov
Research & Guidelines
Related Indicators
Medically Reviewed by Dr. Binoy Babu, MBBS
Board Certified Doctor • 10+ Years Clinical Experience
Dr. Babu is a practicing physician dedicated to empowering patients with clear, actionable medical information. He founded 2opi to bridge the gap between complex lab reports and patient understanding, ensuring everyone has access to a reliable second opinion.
Get Notified When Dr. Babu Is Available